Bifidobacterium animalis subsp. lactis is widely used as a probiotic; however, the presence of the tetracycline resistance gene tetW raises safety and regulatory concerns due to its potential mobility within the gut microbiome. Here, we applied a Safe‐by‐Design strategy using the endogenous CRISPR‐Cas system of B. animalis subsp. lactis BLC01 to inactivate tetW through the introduction of premature stop codons. Whole‐genome sequencing confirmed the intended editing and excluded relevant off‐target effects. tetW inactivation markedly reduced the tetracycline minimum inhibitory concentration, restoring susceptibility below the tetracycline cut‐off value for bifidobacteria (8 μg/mL). Comparative phenotypic analyses demonstrated that the edited strain (BLC01‐2F3G10) retained key probiotic traits, including tolerance to acid, bile, and osmotic stress, exopolysaccharide production, aggregation capacity, survival during simulated gastrointestinal digestion and adhesion to intestinal epithelial cells. Importantly, no reversion to tetracycline resistance was observed after prolonged exposure to sub‐inhibitory minimal selective antimicrobial concentration, indicating genetic stability of the edited phenotype. Collectively, these findings demonstrate that endogenous CRISPR‐based genome editing can be leveraged to selectively remove antimicrobial resistance determinants from probiotic strains while preserving functionality, supporting the development of next‐generation probiotics with an improved safety profile and reduced potential for antimicrobial resistance dissemination in the human gut.
This study evaluated the microbiological, nutritional, sensory, and in vitro biological properties of probiotic fermented milks enriched with 5% Prickly Pear Seed (PPS) flour. Different formulations were tested: plain fermented milk (Control), control with adjunct lactobacilli with probiotic traits (Lactiplantibacillus plantarum LPAL; Lacticaseibacillus casei BGP 93; Lacticaseibacillus rhamnosus LR B; Lacticaseibacillus paracasei LC4 P1), fermented milk with PPS, and fermented milk with PPS and adjunct lactobacilli. PPS flour did not affect the starters or the adjunct lactobacilli viability. Throughout 40 days of storage, probiotic levels remained above the minimum threshold required for health benefits. PPS supplementation increased the in vitro antioxidant activity of the fermented milk formulations only when combined with some of the adjunct lactobacilli. The formulation containing PPS and L. casei BGP 93 (PPS_BGP93) exhibited superior antioxidant performance. In HCT8 cell lines, PPS and PPS_BGP93 reduced Reactive Oxygen Species levels. PPS_BGP93 also upregulated IL-10 gene expression, although this response was not consistent with that found in the presence of LPS after 40 days of storage. PPS and PPS_BGP93 displayed the highest mineral levels and total fiber (around 3%), allowing the nutrition claims to be a source of phosphorus, magnesium, and fiber. A panel test (0–9 scores) revealed that although mouthfeel was impaired by the enrichment of PPS, the PPS-enriched formulations achieved scores around 6 for overall acceptability.